Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Olympus Corp ADR (OCPNY)

Olympus Corp ADR (OCPNY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 26,977,550
  • Shares Outstanding, K 1,370,915
  • Annual Sales, $ 7,336 M
  • Annual Income, $ 475,360 K
  • 60-Month Beta 0.62
  • Price/Sales 3.71
  • Price/Cash Flow 24.53
  • Price/Book 8.07
Trade OCPNY with:
  • Price/Earnings ttm 70.75
  • Earnings Per Share ttm 0.28
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/04/20
  • Annual Dividend & Yield 0.07 (0.35%)
  • Most Recent Dividend 0.069 on 05/27/20
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.02
  • Number of Estimates 1
  • High Estimate -0.02
  • Low Estimate -0.02
  • Prior Year 0.19
  • Growth Rate Est. (year over year) -110.53%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.4000 +1.44%
on 10/16/20
21.6500 -9.11%
on 10/02/20
-0.6915 (-3.39%)
since 09/18/20
3-Month
17.8300 +10.37%
on 07/31/20
21.6500 -9.11%
on 10/02/20
+1.3185 (+7.18%)
since 07/20/20
52-Week
11.0900 +77.44%
on 03/23/20
21.6500 -9.11%
on 10/02/20
+6.3685 (+47.85%)
since 10/18/19

Most Recent Stories

More News
Global Rechargeable Poly Lithium-Ion Battery Market By Structure, By Application, By Region, Industry Analysis and Forecast, 2020 - 2026

, /PRNewswire/ -- The Global Rechargeable Poly Lithium-Ion Battery Market size is expected to reach by 2026, rising at a market growth of 6.9% CAGR during the forecast period. Lithium-ion polymer battery...

MSI : 170.78 (+1.11%)
NINOY : 6.3200 (+7.85%)
OCPNY : 19.6785 (-0.66%)
SSDIF : 46.1178 (-18.39%)
SNE : 75.24 (-0.44%)
TOSBF : 27.8710 (+0.11%)
U.S. Gynecology Robotic Surgery Market worth USD 1.38 Billion at 6.8% CAGR; Rising Demand for Minimally Invasive Procedures to Aid Growth: Fortune Business Insights(TM)

The U.S. gynecology robotic surgery market is set to gain traction from the increasing shift towards minimally invasive procedures over open surgeries as they have lower readmission rates, fewer complications,...

MDT : 109.25 (+0.09%)
OCPNY : 19.6785 (-0.66%)
TITXF : 0.1930 (-1.03%)
Forecast [2019-2026], Smart Pills Market Size, Share, Growth, Trends, Analysis, Revenue, Competitive Landscape Report by Fortune Business Insights(TM)

The global smart pills market is set to gain traction from the increasing usage of these non-invasive devices for the diagnosis of gastrointestinal disorders and cancer. They can ever replace the traditional...

MDT : 109.25 (+0.09%)
OCPNY : 19.6785 (-0.66%)
Olympus Launches ENDO-AID, an AI-Powered Platform for Its Endoscopy System

Olympus Corporation today announced the launch of ENDO-AID(1), a cutting-edge platform powered by artificial intelligence (AI) that includes the endoscopy application ENDO-AID CADe (computer-aided detection)...

MDSY : 0.73 (+4.29%)
OCPNY : 19.6785 (-0.66%)
Ureteroscope Market to Rise at 5.5% CAGR and Touch USD 1,498.1 Million by 2027; Promising Advancements in the Field of Urological Devices to Propel Market Expansion: Fortune Business Insights(TM)

The global ureteroscope market size is projected to reach USD 1,498.1 million by 2027, exhibiting a CAGR of 5.5% during the forecast period. Increasing incidence of kidney stones is expected to stoke adoption...

OCPNY : 19.6785 (-0.66%)
Laser interferometer market is expected to grow at CAGR of 7.1 % from 2020 to 2025

NEW YEAR, /PRNewswire/ --Read the full report: The global laser interferometer market is expected to grow from in 2020 to by 2025; it is expected to grow at a CAGR of 7.1% during 2020â€"2025. Key...

KEYS : 106.98 (+1.45%)
OCPNY : 19.6785 (-0.66%)
RNSHY : 24.3000 (unch)
Kidney Stone Management Market to Hit USD 2.21 Billion by 2027 with 5.3% CAGR: Popularity of Miniaturized Surgeries to Boost Growth, says Fortune Business Insights(TM)

Global kidney stone management market size is expected to rise prominently on account of the increasing cases of kidney stone among people worldwide. This is further attributed to the formation of crystal-like...

BSX : 37.26 (-0.75%)
BCR : 331.24 (-0.59%)
OCPNY : 19.6785 (-0.66%)
Ureteroscope Market Research Report by Type, by Usage, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

, /PRNewswire/ -- Read the full report: The Global Ureteroscope Market is expected to grow from in 2019 to by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.23%.Market Segmentation &...

MDSY : 0.73 (+4.29%)
OCPNY : 19.6785 (-0.66%)
SYK : 221.25 (+0.20%)
3D Optical Metrology Market Research Report by Type, by Component, by Industry, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

, /PRNewswire/ --

AME : 108.68 (-0.02%)
FARO : 65.21 (+1.09%)
HXGBY : 78.0000 (+1.57%)
NINOY : 6.3200 (+7.85%)
OCPNY : 19.6785 (-0.66%)
RNSHY : 24.3000 (unch)
Nasal Splints Global Market Report 2020-30: Covid 19 Impact and Recovery

Reportlinker.com announces the release of the report "Nasal Splints Global Market Report 2020-30: Covid 19 Impact and Recovery" - https://www.reportlinker.com/p05967829/?utm_source=GNW

MDT : 109.25 (+0.09%)
OCPNY : 19.6785 (-0.66%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 19.7662
1st Resistance Point 19.7223
Last Price 19.6785
1st Support Level 19.6223
2nd Support Level 19.5662

See More

52-Week High 21.6500
Last Price 19.6785
Fibonacci 61.8% 17.6161
Fibonacci 50% 16.3700
Fibonacci 38.2% 15.1239
52-Week Low 11.0900

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar